Short‐term clinical observations of belimumab in the treatment of recently diagnosed systemic lupus erythematosus
Abstract Objective To explore the therapeutic effectiveness and safety of belimumab in the treatment of recently diagnosed systemic lupus erythematosus (SLE). Methods Between January 2019 and February 2022, a total of 30 patients who had been recently diagnosed with SLE were selected for 6 months of...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-11-01
|
| Series: | Immunity, Inflammation and Disease |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iid3.716 |